Found: 10
Select item for more details and to access through your institution.
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002)
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1267, doi. 10.1007/s00280-015-2755-2
- By:
- Publication type:
- Article
Phase II study of carboplatin and pemetrexed in advanced non-squamous, non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0902.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 2, p. 271, doi. 10.1007/s00280-012-1910-2
- By:
- Publication type:
- Article
Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: Multicenter, single-arm, phase 2 trial (ABC Study).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302.
- Published in:
- Oncology, 2019, v. 97, n. 6, p. 327, doi. 10.1159/000501967
- By:
- Publication type:
- Article
Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report.
- Published in:
- Molecular & Clinical Oncology, 2019, v. 10, n. 2, p. 267
- By:
- Publication type:
- Article
A statistical issue regarding the original paper by M. Tamiya and others (Med Oncol (2016) 33:2 DOI 10.1007/s12032-015-0715-7).
- Published in:
- 2017
- By:
- Publication type:
- Letter